Syneos Health (SYNH) Stock Price, News & Analysis

Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Key Stats

• Today's Range: $42.98 to $42.98
• 50-Day Range: $42.48 to $42.98
• 52-Week Range: $22.89 to $52.23
• Volume: N/A
• Average Volume: 1.92 million shs
• Market Capitalization: $4.46 billion
• P/E Ratio: 62.29
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SYNH Stock Analysis - Frequently Asked Questions

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The firm's revenue for the quarter was up 22.7% compared to the same quarter last year.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Syneos Health investors own include AT&T (T), NVIDIA (NVDA), Bristol-Myers Squibb (BMY), PayPal (PYPL), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Intel (INTC).

Company Calendar

• Last Earnings: 11/03/2021
• Today: 6/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SYNH
• CIK: 1610950
• Web: www.syneoshealth.com
• Phone: (919) 876-9300
• Fax: 919-876-9360
• Employees: 28,768
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.69
• Trailing P/E Ratio: 62.29
• Forward P/E Ratio: 15.41
• P/E Growth: N/A
• Net Income: $266.50 million
• Net Margins: 1.31%
• Pretax Margin: 1.53%
• Return on Equity: 8.63%
• Return on Assets: 3.66%

Debt

• Debt-to-Equity Ratio: 0.77
• Current Ratio: 1.20
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $5.39 billion
• Price / Sales: 0.83
• Cash Flow: $6.72 per share
• Price / Cash Flow: 6.40
• Book Value: $33.96 per share
• Price / Book: 1.27

Miscellaneous

• Outstanding Shares: 103,720,000
• Free Float: 103,366,000
• Market Cap: $4.46 billion
• Optionable: Optionable
• Beta: 1.58